These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology. Jalal SI; Riggs HD; Melnyk A; Richards D; Agarwala A; Neubauer M; Ansari R; Govindan R; Bruetman D; Fisher W; Breen T; Johnson CS; Yu M; Einhorn L; Hanna N Ann Oncol; 2012 Jul; 23(7):1730-8. PubMed ID: 22156624 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers are here to stay for clinical research and standard care. Bunn PA; Hirsch FR; Doebele RC; Camidge DR; Varella-Garcia M; Franklin W J Thorac Oncol; 2010 Aug; 5(8):1113-5. PubMed ID: 20661083 [No Abstract] [Full Text] [Related]
6. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy. Hirsch FR; Herbst RS; Olsen C; Chansky K; Crowley J; Kelly K; Franklin WA; Bunn PA; Varella-Garcia M; Gandara DR J Clin Oncol; 2008 Jul; 26(20):3351-7. PubMed ID: 18612151 [TBL] [Abstract][Full Text] [Related]
8. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Bean J; Brennan C; Shih JY; Riely G; Viale A; Wang L; Chitale D; Motoi N; Szoke J; Broderick S; Balak M; Chang WC; Yu CJ; Gazdar A; Pass H; Rusch V; Gerald W; Huang SF; Yang PC; Miller V; Ladanyi M; Yang CH; Pao W Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20932-7. PubMed ID: 18093943 [TBL] [Abstract][Full Text] [Related]
9. EGFR inhibitors in the treatment of lung cancer. Hirsch FR Onkologie; 2007 Oct; 30(10):476. PubMed ID: 17890885 [No Abstract] [Full Text] [Related]
10. Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer. Lin CS; Liu TC; Lai JC; Yang SF; Tsao TC Int J Med Sci; 2017; 14(13):1410-1417. PubMed ID: 29200955 [TBL] [Abstract][Full Text] [Related]
12. Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC. Kalikaki A; Koutsopoulos A; Trypaki M; Souglakos J; Stathopoulos E; Georgoulias V; Mavroudis D; Voutsina A Br J Cancer; 2008 Sep; 99(6):923-9. PubMed ID: 19238633 [TBL] [Abstract][Full Text] [Related]
13. EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer. Dubey S; Stephenson P; Levy DE; Miller JA; Keller SM; Schiller JH; Johnson DH; Kolesar JM; J Thorac Oncol; 2006 Jun; 1(5):406-12. PubMed ID: 17409891 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer. Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605 [TBL] [Abstract][Full Text] [Related]
15. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer. Han SW; Jeon YK; Lee KH; Keam B; Hwang PG; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Heo DS; Bang YJ; Kim TY Pharmacogenet Genomics; 2007 May; 17(5):313-9. PubMed ID: 17429313 [TBL] [Abstract][Full Text] [Related]
16. Rare mutations in non-small-cell lung cancer. D'Arcangelo M; D'Incecco A; Cappuzzo F Future Oncol; 2013 May; 9(5):699-711. PubMed ID: 23647298 [TBL] [Abstract][Full Text] [Related]
17. Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer. Tan CS; Cho BC; Soo RA Lung Cancer; 2016 Mar; 93():59-68. PubMed ID: 26898616 [TBL] [Abstract][Full Text] [Related]